ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

NCI prepares for third hearing on conflicts of interest.

June 18, 2004

European Commission Approves Subcutaneous Rituximab

March 28, 2014

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires

June 16, 1989